- Advertise
- Contact Us
- Contribute
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
- About Us
© 2021 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
Women's Health
The Endocrinology Network® Women’s Health clinical resource center is a hub of news and information related to health of women at all ages and stages of life. This page offers perspective and insight on the latest information from multiple fields of women’s health, including gestational diabetes, hormone therapy, menopause management, and reproductive health.
FDA Makes Historic First Approving NEXTSTELLIS, an Oral Contraceptive Containing E4
April 20, 2021
The approval, which was awarded to Mayne Pharma, makes NEXTSTELLIS the first and only contraceptive pill containing E4, a natural occurring estrogen to receive approval from the FDA.
Study Finds Risk of Kidney Stones Increases During and Immediately After Pregnancy
April 15, 2021
An analysis of nearly 3k women from a single county in Minnesota suggests pregnancy was associated with an increased risk of kidney stones and results provide insight into when this apparent risk peaks and subsides.
Obesity Tied to Heavy Menstrual Bleeding, Delayed Repair in Womb Lining
April 13, 2021
An analysis of body weight and PBAC score from 121 women in Scotland suggests the presence of obesity could be linked to heavier menstrual bleeding and cause delays in womb lining repair.
Disparities in Failure to Rescue Rates Drives Racial Differences in Maternal Mortality
April 09, 2021
While data indicates care has improved, a retrospective study from investigators at Columbia University suggests differences in rates of failure to rescue from severe maternal morbidity were a major contributor to the disparity in excess maternal mortality seen among Black women.
Adverse Pregnancy Outcomes can Influence CVD Risk Later in Life
April 04, 2021
Dr. Nisha Parikh provides additional insight into the AHA's latest scientific statement, which highlights the need for greater attention and emphasis on the impact of adverse pregnancy outcomes on cardiovascular risk in women.
Exposure to Endocrine-Disrupting Chemicals Can Increase Risk of Postpartum Depression
April 02, 2021
An analysis of nearly 150 pregnant women presenting NY-based medical centers suggests prenatal exposure to endocrine-disrupting chemicals in plastics could increase odds of developing postpartum depression.
Alternating Doses of Denosumab Therapy Equally as Effective, Real-World Study Finds
March 24, 2021
Switching from 60 mg to 30 mg denosumab every 6 months could be an option for patients who have completed long-term denosumab therapy, according to the results of a new study from McMaster University.
Black Women with PCOS at Greater Cardiometabolic Risk than White Counterparts
March 22, 2021
A meta-analysis of nearly a dozen studies presented at ENDO 2021 suggests Black women with PCOS were at an increased cardiometabolic risk, despite having comparable fasting glucose and lower triglyceride levels.
Comparing ADA vs. ACOG Approaches for Gestational Diabetes Screenings
March 16, 2021
A trial of more than 20k women from investigators at Kaiser Permanente found there were no significant differences in outcomes among pregnant women undergoing gestational diabetes screenings using the ADA's 1-step approach versus the ACOG's 2-step approach.
Type 1 Diabetes Shortens Reproductive Lifespan in Women
March 04, 2021
An analysis of data from 2 major studies suggests women with childhood-onset type 1 diabetes experienced 2.5 fewer reproductive years than their counterparts without diabetes.